Introduction
~-Amylase in human serum consists of at least two isoenzymes originating from either the pancreas or all salivary glands, but hundred-to thousand-fold lower concentrations of both types have been found in various other tissues (8), and a novel type was detected in lung carcinoid tumour (9). The human pancreatic and salivary isoenzymes are single polypeptide chains forming three structural domains composed of 496 amino acids with about 97 per cent homology (10,11) with one calcium and one chloride ion and almost identical catalytic and immunogenic / properties which can only be distinguished by monoclonal antibodies (12).
More than two hundred e~-amylase methods based on various polymeric substrates had been developed before the era of kinetic measurements which use maltotetraose, maltopentaose or, mostly, numerous nitrophenylated oligosaccharides together with ~-glucosidase (~-D-glucoside glucohydrolase, EC 3.2.1.20). The latter tests have become increasingly popular despite their complicated stoichiometry. However, recently the components of an assay have become available, which uses a novel-type ~-glucosidase completely hydrolyzing nitrophenylated substrates. Thus, the cleavage of one r linkage by ~-amybee results in the release of one molecule of 4-nitrophenol. The following method describes the optimized conditions of this assay (13).
The principles applied in the selection of the conditions of measurement are those stated in a previous publication by this committee (1). Since elevated s-amylase activity in serum and urine is generally accepted as a reliable sign of pancreatic disease, the method was optimized for pancreatic amylase, but it is also suited, although less optimally, for the determination of salivary amylase. o~-Glucosiclaes** > (7-x) xGlucose+ 4-Nitrophenol
Principle
The reaction is continuously monitored by measuring the increase of the yellow product 4-nitrophenoxide at 405 nm.
IFCC Conditions for Measurement
All reaction conditions have been chosen on the basis of uni-and multivariate experiments with purified human pancreatic amylase (14,15) and have been confirmed with sera from patients suffering from acute pancreatitis.
These IFCC conditions are optimized reaction conditions which are most favourable for both the kinetic reactions and the technical aspects of the measurement, i.e. they do not necessarily provide maximal activity (1) . 
Instrumentation and Equipment
A spectrometeror spectrum-line spectrometer (preferably a recording instrument suitable for accurate measurement at 405 nm) with constant temperature cuvette compartment is required. Specifications for the equipment (e.g. volumetric glassware, pH meter, performance of the spectrometer, and temperaturecontrol), sampteand reagent handling should meet those of previo~,~ IFC~ recommendations (1-7), B, Reagents 1. Sodium chloride, NaCI, Mr 58,44 2. Calcium chloride, dihydrate, CaCI2.2H20, Mr 147,02 3. N-2-Hydroxyet hylpiperazine-N'-ethanesulfonic acid, C6H18N204S, Mr 238,31 4. Sodium hydroxide, NaOH, Mr40,00 (0,2 mo I/I) 5. ~-Glucosidase (EC 3.2.1.20) from Bacillus stearothermophilus (lyophilized). Specific activity higher than 400 pkat / g (30~ 6. 4,6-Ethylidene (GT)-4-nitrephenyt (G1)~-(1->4)-D-maltoheptaoslde, C~oH~NO ~, Mr 1300,2
Purity of Reagents
Specifications regarding the purity of reagents must conform to the criteria given in previous recommendations (1) . 4,6-Ethylidene (G7)-4-nitrophenyl (G1)-cc-(1->4)-D-maltoheptaoside must be of highest available purity (_>0, 95 by high performance liqiuid chromatography, mass fraction >__0,90, pH 6,20 in aqueous solution). ~-Glucosidase must contain >_ 400 pkat / g (24 kU/g at 30~ corresponding to >667 pkatl g (40 kU/g at 37~ Its relative contamination with s-amylase should not exceed 1 x 10 .4 kat/kat. Calcium chloride, sodium chloride, sodium hydroxide, and N.2-hydroxyethylpiperazine-N'-ethanesulfonlc acid must be of Analytical Reagent grade. Commercial preparations (crystalline or off-white powder) generally meet these requirements. Further details are given in Appendix B.
Preparation of Solutions
To prevent the growth of microorganisms in solutions, use sterile containers. Solutions must be prepared in volumetric glassware of Class A specifications at the calibration temperature with doubly distilled deionized water (sterile; conductivity below 2 pS; pH 6-7; silicates <0,1 mg / I). The pH of solutions must be adjusted at 30~ with a pH meter calibrated at 300C with standardized reference buffers
(I).
Stock solution of calcium chloride (calcium chloride, 258 mmol / I).
Dissolve 3,80 g of calcium chloride, dihydrate, in about 80 ml and make up to 100 ml with water. Lorentz I FCC Method for co-Amylase Solution of effectors in buffer (sodium chloride, 72,3 mmol / I; calcium chloride, 1,03 mmol / I; N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid, 51,7 mmol/I; pH 7,12 at 30oC).
Dissolve 1,057 g of sodium chloride and 3,078 g of N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid in about 200 ml of water, add 1,0 ml of solution I, adjust to pH 7,12 at 30~ with approximately 24 ml of sodium hydroxide, 0,2 mol / I, and add water to exactly 250 ml.
Specimen Procurement, Stability and Storage
Serum and hepadnized plasma are acceptable materials. Fluoride and ethylenediaminetetraacetate must not be used as anticoagulants, although the calcium concentration of solutions III and IV reactivates the enzyme. Collect blood by venipuncture with minimal stasis. Blood cells should be removed from serum or plasma within two hours of collection. Urine may be a specimen for special clinical requests.
III

IV
Working solution of buffer-effector-enzyme mixture (sodium chloride, 72,3 mmol / I; calcium chloride, 1,03 mmol / I; o~-glucosidase 100 pkat / I (6 kU / I); N-2-hydroxy ethylpiperazine-N'-ethanesulfonic acid, 51,7 mmol / I; pH 7,12 at 30~ Dissolve 10 pkat (600 U) of ~-glucosidase from microorganisms, e.g. 25 mg of a preparation containing 400 pkat / g, in 100 ml of solution I1.
Substrate solution (initiating reagent: 4,6-ethylidene (G7)-4-nitrophenyl) G1)-~-(1->4)-D-maltoheptaoside, 31 mrnol / I); sodium chloride, 72,3 mmol / I; calcium chloride, 1,03 mmol / I; N-2-hydroxyethylpiperazine-N'-ethanesul-fonic acid, 51,7 mmol / I; pH 7,06 at 30~ (~-Amylase is relatively stable. Single freezing and thawing of serum does not impair its activity which is fully retained during storage for 4 days at 20~ 2 weeks at 5~ 1 year at -28~ or 5 years at -75~ Urine should not be frozen but should be analyzed within 12 hours at 20~ or 5 days at 5~ and preservatives should not be added. Dissolve 0,9 g of sodium chloride in 100 ml of water.
Measurement
Measurement conditions
Stability of Solutions
Handling of solutions
Before pipetting, reagents and samples must be brought to the pipettes' calibration temperature. However, use of other temperatures results in a relative error of only 0,000025 for each ~ difference from the calibration temperature. During the preincubation period the solution in the cuvettes must attain a temperature of 30,0~ before initiating the reaction by addition of the substrate.
Solutions I and V are indefinitely stable at 20~ If not sterlized by boiling, solution II has a shelf life of at least four weeks at 20oC. Solution III and IV are at least stable for two weeks at 5~ Bacterial or ft, r~gal contamination limit their stability. Do not add ~zide as a biocide.
Subprocedures that constitute one measurement
The measurement consists of two subprocedures: the overall reaction comprising the catalysed plus the spontaneous substrate hydrolysis and the reagent blank reaction, representing the latter only, which is very small, viz. about 0,0005 ANmin. For practical purposes it may be disregarded. A sample blank measurement is not necessary.
10,4 Measurement interval
A lag phase of 180 s must be observed. The values for ANA t of the overall reaction are constant over a period of at least 300 s following the lag phase for samples with catalytic concentrations of s-amylase upto 11,5 pkat / I (or 12,5 pkat / I for sera, resp., see Calculation). If the increase of absorbance is greater than 0,235 per 60 s corresponding to 11,5 pkat / I [689 U / I], the sample must be exactly diluted with solution V, and the resulting ANA t has to be adequately multiplied.
Reagent blank
The same procedure is followed for the measurement of the reagent blank except that the sample is replaced by solution V. A reagent blank absorbance change must be determined for each series of samples. The initial absorbance sl~ould not be above 0,120 and Indian Journal of Clinical Biochemistry, 1997, 12 (1) , the change of absorbance should be less than 0,0005 per 60 s at 405 nm. Otherwise the purity of the reagents must be reassessed.
Correction for blank reaction
The reagent blank has to be substracted from the overall reaction as follows: ( ANt, t) overall-(t~Nht) corrected = a. 
Analytical Variability
Performance data with the described measurement procedure are given in table 2. 
Reference Values
Preliminary reference ranges were derived by assessbg (x-amylase in 100 sera of apparently healthy people according to a priori selection (16) with following exclusion criteria: Postprandial glucose above 6,4 mmol / I, creatinine above 90 (females) or 110 (males) pmol / I, y-glutamyltransferase above 0,45 pkat / I (30~ 4) and total protein below 58 g / I. Ten groups were established, each comprising 10 women or 10 men in each of the five decennla between 20 and 59 years of age. Since no sex-or age-related differences between these groups were observed by the Mann-Whitney U test, the O,95-reference interval of 0,40 pkat / I (24 U / I) to 1,10 pkat / I (66 U/I) was generated from all data, whose natural logarithms showed gausslan distribution. Separate reference intervals for both sexes are presented in table 3. 
Introduction
The optimization of measurement conditions for (z-amylase in this coupled test was not influenced by the indicator system, so that all analytical variables of the primary reaction could be investigated without limitation (except some buffers noted below). We applied univariate experiments, since there were no interactions between buffer species and strength, pH, substrate, and effectors. The results, based on the release of 4-nitrophenol/4-nitrophenoxide, were confirmed by response surface methodology, and the choice of conditions considers enzyme kinetics as well as the technical aspects of performance that are consistent with robustness and transferability of the method.
2, Buffer and pH
On principle, both (z-amylases display bread optima at neutral pH with less than 2% difference in activity between pH 6,9 and pH 7,2 slightly depending on buffer type and temperature. The maximum for human pancreatic amylase lies close to pH 7,10, whereas that of the salivary component is between pH 6,9 and 7,0 under the conditions of the assay (figure !). N-(2-Acetamido) imin(~diacetic acid complexes the intrinsic calcium atom ef (z-amylase, while the amino type buffers bis (2-hydroxyethyl) aminotris(hydroxy-methyl) methane and 1,3-bis [tris(hydroxymethyl)-methylaminopropane inhibit the indicator enzyme (x-glucosidase (table 1) .
Both isoamylases show higher activities in zwitterionic buffers than in phosphate, so that 3-(Nmorpholino)propanesulfonicacid (pKa 7,09), N,N'-bis (2-hydroxyethyl)-2-aminoethanesu~onic acid (pKa 7, 09) and N-2-hydroxyethylpiperazine-N'-ethanesulfonicacid (pKa 7,41, at 30~ each) wereconsidered for measure- Biochemistry, 1997, 12 (1), ment. Although the pK-values of the former two closelycorrespondtotheoptimalpHofthepancreatic isoenzyme, N-2-hyd roxyethylpiperazine-N'-ethanesulfonic acid was chosen bytwo reasons: Most of the sera from patients with acute pancreatitis produce higher conversion rates with this buffer, and an adaptation of the proposed method for routine use (at 37~ shiftsthe maximum to pH 7,15 and lowers the pKato7,31. Trimethylpyridine is not throughout available In the required quality and was, therefore, declined. 
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Substrate, Chloride and Oalcium Concentration
The depender~ce of reaction velocity on substrate concentration was followed up to 4,6-ethylidene(G7)-4-nitrophenyl(G1)-~-D-maltoheptaoside, 10 mmol/I, where maximum velocity (Vmax) is attained. Substrate inhibition does not take place, and high concentrations do not noticeably increase the reagent blank. For practical (mainly economic) reasons 5,0 mmol / I, which yield >_0,96 Vmax for both isoamylases, were selected.
~-amylases undergo allosteric activation by halides and other monovalent anions chloride being the most effective one (1), Hence, the activity profile of hu man pancreatiQ and salivan/amylase by varying the chloride concentration was recerded by increasing the sodium chloride concentration upto 150 mmol / I. Maximal velocity with the pancreatic isoenzyme occurs at 80 mmel t I, whereas human salivary ~-amylase requires about 120 mmol/I. At 70 mmol/I, the concentration chosen, >__0,99 Vmax and 0,95 Vmax, respectively, are obtained. Like chloride, which is located near the active site in domain A of the three structural domains, the calcium ion in a pocket of domain B (2) forms an essential component of o~-amylase stabilizing the enzyme molecule and retaining its activity (3) . No effect was observed by varying the calcium chloride concentration between 0 and 10 mmol / I without changing the other conditions of the optimized assay. However, to protect the enzyme against complexing agents in the sample (citrate, traces of ethylenediaminetetraacetate) calcium chloride, 1,0 mmol / 1, was included in the assay.
The Catalyzed Reaction
Both human pancreatic and salivary co-amylase Accepting the five-subsite model (5) for the active site of s-amylase with the catalytic site between subsites 2 and 3 ( figure 4A ), where substrates are exclusively cleft between two glucose residues required for productive binding at these subsites. This endo-type activity of s-amylase towards substrates consisting of five or more unmodified glucose residues exerts maximal reaction rates about pH 7,0 yielding maltose and maltotrlose as terminal products.
The release of three reaction products from 4,6-ethylidene(G7)-4-nitmpher~(G1)-~-D-maltoheptaosk~ conforms well to this model, because all subsites are specifically occupied by glucose residues in the distinctly favoured cleavage to 4-nitrophenyl-o~-Dmaltoside (B) and 4-nit rophenyl-=-D-maltotrioside (C). Subsite 3 absolutely requires unmofified glucose, whereas subsites 2 and 4 allow minor modifications viz. hydroxyethylation, at C-3 and C-6 or C-2 and C-6 of the respective residues (6). The specifity of subsite 5 is poor, thus allowing a weak productive binding of the bulky ethylidene glucose with the subsequent production of the small 4-nitrophenyl-o~-D-maltotetraoside fraction (D).
Indicator Reaction
Adition of ~x-glucosidaee is necesary to release the chromophore from the three nitrophenylated reaction products mentioned above. Table 4 shows the relationship between the catalytic concentration of the indicator enzyme and the time lag before achieving linear conversion rates after initiating the reaction. Other experiments showed that 80 pkat / I of ~-glucosidase completely hydrolyzed all reaction products which might have been generated by a sample of s-amylase containing 43 pkat / I (corresponding to 1,39 pkat / I in the reaction mixture) during the lag phase (table 5).
Temperature Dependence
Plotting the logarithm of the respective reaction velocity against the reciprocal absolute temperature gives a straight line between 25 and 37~ with a discontinuity of this slope below the transition temperature of 25"C ( tween a sample start and the proposed substrate start for samples containing between 0,60 (30) and 6,0 pkat / I (360 U / I) of (x-amylase.
Measurement interval, time of linear response and dynamic range
The lag phase has to be obeyed, Linear conversion rates are always observed for catalytic concentration upto 12,2 pkat/I (735 U/I), i.e. 11 times the upper reference limit, if the reaction is monitored no longer than 300 s (table 7) .
The data of table 7 allow measurements up 0,235N60 s, since the assay of those samples diluted with nine volumes of sodium chloride, 154 mmol / I, leads to fractional activities of 0,97 -1,03 after multiplication. Therefore, the dynamic range is set according to the results of figure 5, and sera containing more than 12,5 IJkat / I (750 U / I) should be adequately diluted.
Reagent stability, reagent blank and sensitivity of the assay
As stated above, solutions III and IV are prone to microbial and fungal growth, but their stability may be enhanced, e.g. by methylisothiazolone, 0,1 g / I. Solution IV proved stable only in the proposed formulation or with N,N'-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid but not with phosphate as buffer substance. 4,6-Ethylidene (G7)-4-nitrophenyl (G1)-o~-(1 ->4)-D-maltoheptaoside may be stored for at least two months at 5~ in aqueous stock solutions above 50 mmol / I. Spontaneous substrate hydrolysis is extremely low, so that the average reagent blank is 0,25 U / I. Criteria for the sensitivity of the assay as proposed by Gautschi et al. (7) are shown in table 8. 4 Interferences and sample blank The detrimental effect of calcium complexing agent= has been already stressed. Although tfm calclurn concentration In the reaction mixture restores the activity of tile enzyme, the use of anticoagulants other than hepartn (up to 200 U/I or sodium heparinate, 1 g / I) is not recommended, 100+ 3 p.c. m-amylase recovery (at 1,2 pkat / I) is noted with following concentrations of endogenous serum components: Glucose, 55 mmol / I, triacylglycerois, 25 mmol / I, bilirubin, 500 pmol/I, ascorbic acid 1 mmol / I, and haemoglobin, 2,5 g / I.
Evaluation of the Selected Conditions by Multivariate Analysis
The method is optimized for human pancreatic amylase but is also well sufled for the measurement of salivary amylase as can be deduced by the results of computerized Response Surface Methodology.
Optimal concentrations of substrata, chloride and pH were not interdependent, interactions between these variables were weak, Maximal a=ivity for pancreatic amylase Is 0b- The thermodynamic ionization constant of 4-nitrophenol was found to be 7,10 x 10 -8 at 25oC (1) under conditions similar to those of the assay, i.e. almost equal amounts of 4-nitrophenol and 4-nitrophenoxide are released bythe proposed method, and small variations in pH, ionic strength, temperature and protein concentration will considerably influence the absorbance of the final reaction product to be measured. Hence, these conditions have to be carefully examined and exactly observed.
Although the study of analytical variables has to concentrate on the measurement of o~-amylase, relevant properties of (z-glucosidase, e.g. pH profile and influence of effectors must fit the reaction conditions of the proposed method. The indicator enzyme must not attack 4,6-ethylidene (G7)-4-nitrophenyl(G 1 ) ~-(1 ->4)-D-rnaltoheptaoside, which can be ascertained by the reagent blank. Moreover, Lorentz I FCC Method f or (~-Amylase o~-glucosidase must completely release the chromophore without time lag from all 4-nitrophenyl oligosaccharides generated by o~-amylase, and this has to be proved by assessing its required catalytic concentration and by high performance chromatography of the product patterns.
Spectral Properties of 4-Nitrophenol
Commercially available material must meet the specifications given by Bowers et al. (2) or it has to be purified best by sublimation according to their instructions. The calculation of molar absorption coefficients was based on measuring 4-nitrophenol solutions, 100 pmoVI, with a 0,5 nm bandwidth spectrometer. The spectrometric data presented in table 1 and figure 1 should be met within a range of • p.c. with instruments used for this method.
Perusal of table I shows that the ionization of 4-nitrophenol is suppressed by protein and is enhanced by temperature, both effects being maximal at the pK value of 7,15 at 25oC (1). The increase is compensated in N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid buffer by a negative temperature coefficient of -0,014 ApKa/~ making the indicator less susceptible to temperature effects. The absorbance was less decreased by various patients' sera (including dysproteinaemic and paraproteinaemic samples) than by human serum albumin. Thus, the calculation of catalytic activities in sera should be appropriately based on an empirical molar absorption coefficient of 975 m2/mol at 405 nm and 30~ The presence of proteins does not change the spectrum of the chromophore. The bathochromic shift of the spectral maximum with temperature is only slight, and the molar absorption coefficient of the substrate at 405 nm(< 1,2 m2/mol) can be disregarded. D-maltoside-maitotrioside and-maltotetraoside, ought to be completely degraded to free the chromophore. Thus, conclusions from the following results must be drawn in the light of the primary reaction. Dissolve 10 mg of ~-glucosidase from microorganism (e.g. Bacillus stearothermophilus) containing 400 pkat / g (24 kU/g, 30~ and 80 mg of human serum albumin with N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid, 50 mmol / I; pH 7,12 at 30~ up to 4,0 ml. The solution may be stored at 5~ for four weeks or at -28~ for at least 1 year.
A working solution with about 5 pkat / I (300 U / I) should be prepared within 5 hours before use by dilution with solution A.
Measurement procedure
The measurement consists of the overall reaction minus the reagent blank reaction as follows : (ANAt) overall -(ANAt) blank = ( ANAt)corrected = a, Solution A replaces the enzyme in the blank reaction, whose increase of absorbance is less than 0,001 ANmin and may be neglected for practical purposes.
Analytical system for measurement of the overall ~-glucosidase rate of conversion. The factors represent the volume ratio (assay/ sample), s 405 for 4-nitrophenol in N-2-hydroxyethylpiperazine-N' ethanesulfonio acid, 50 mmol/I, pH 7,10 at 30~ and the light pathlength, respectively. The influence of the minimal protein concentration in the reaction mixture on the molar absorption coefficient of 4-nitrophenol can be disregarded.
Buffer and pH
The catalytic concentration of o~-glucosidase can be reliably determined by the hydrolysis of 4-nitrophenyl-o~-D-glucopyranoside, but it must be kept in mind that monitoring the cleavage of the maltoside, maltotrioside and maitotetraoside derivatives would better reflect its pertinence as an indicator enzyme for o~-amylase. Thus, additional experiments were carried out with 4-nitrophenyl-o~-D-maltotdoside, whose decrease was determined by chromatography (see 4).
To compare the bacterial enzyme with ~-glucosidase from yeast a variation of activity with pH was done in phosphate ( figure 2) showing an identical activity profile for both the glucoside and the maltotrioside, a similar dependence on pH as the yeast enzyme (3, 4) and a fairly good agreement with the requirements of the primary reaction. In a further approach, therefore, the influence of buffers with pK values near pH 7,1 was studied on enzyme activity under optimized conditions as well for ~-glucosidase as for o-amylase measurement (table 3) . Table 3 confirms the inhibition of o~-glucosidases by amino type buffers and displays only slight differences except N-(2-acetamido)-2-aminoethanesulfonic acid between the action on both substrates. From this point of view phosphate must be regarded as the optimal buffer. This also proves right under the conditions of the (~-amylase assay. Unexpectedly, chloride strongly activated the enzyme in 3-(N-morpholino) propanesulfonic acid and, especially, in 2,4,6-trimethylpyridine buffer, where activity was higher than in phosphate (table 4).
Kinetic constants and product pattern
Contrasting with the yeast enzyme bacterial o~-glucosidase is claimed to cleave higher maltooligosaccharides faster than 4-nitrophenyi-~-Dglucopyranoside. Hence, kinetic constants, relative hydrolysis rates and product patterns were determined under the conditions of the ~-amylase assay. 
Digests of 4-nitrophenylated oligosaccharides
show the enzyme attacking preferably the ultimate bond at the non-reducing end thus acting like a glucoamylase. Obviously, only two products are formed, viz. the oligosaccharide minus and plus 1 glucose residue, but only 25% of the released glucose are transferred to the original substrate. If the degradation is restricted to 5-10% substrate consumption, degradation does not proceed to smaller products (table 6). 
Temperature dependence and stability
The catalytic concentration of o~-glucosidase under the conditions of the s-amylase assay at 30~ (as given in table 2) roughly corresponds to 60% of that in phosphate at pH 7,0 at 37~ Arrhenius plots between 25 and 37~ yield straight lines with almost parallel slopes for the reaction mixture of the ~-amylase assay (Q10 2,05+0,06, activation energy 3,15 + 0,1 kJ/mol) and for phosphate, 50 mmol / I, pH 6,5 (Q10 2,12 + 0,08, activation energy 3,32 + 0,16 kJ/mol).
The enzyme proved stable at 5~ for three weeks either in solution III (working solution) or in analogous mixtures, replacing N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid by 3-(N-morpholino) propanesulfonic acid or by 2, 4,6-trimethylpyridine, but it decayed after 12 days at 20~ storage in these solutions. 
High Performance Liquid Chromatography of Reaction Products
Working parameters
Performance and results of chromatographic procedures
The system is capable to separate 4-nitrophenol and its glucosides to check the purity of the chromophore (figure 3) and to follow the action of o~-glucosidase and e~-amylase on 4-nitrophenyl-~-D-oligosaccharides as well. As an example, the hydrolysis of the substrate is stopped after various times by adding 0,05 volumes of concentrated acetic acid to the assay mixture followed by centrifugation for approximately 300 s with 12000 x g. The chromatography of the supernatant yields a typical order of peaks as demonstrated in figure 3 . Table 7 . Retention times of 4-nitrophenol and some of its glucosides according to the working parameters. 
